Acquired in 2022, the Joondalup facility faced a structural change when one tenant exited while another required expansion.

Through early engagement and decisive execution, Barwon coordinated an early surrender, secured a new 10-year lease and repositioned the asset as a fully leased life sciences facility anchored by Linear Clinical Research.

This case study highlights how active asset management can convert leasing risk into long-term income and capital growth.